What You Should Know:
- Johnson & Johnson’s Janssen Pharmaceuticals company announced it is working with Alveo Technologies, an innovative diagnostic testing company, to help bring its COVID-19 rapid at-home self-testing platform for viral infectious diseases to market.
- Johnson & Johnson’s Janssen Pharmaceuticals company will work with and fund Alveo to accelerate research and development of be.well .
- Alveo will
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
AiCure Launches Platform to Remotely Capture Digital Biomarkers in Clinical Trials
What You Should Know:
- AiCure launches digital biomarker platform to remotely detect subtle changes in a patient's condition, leverages computer vision and AI to gather and analyze visual and auditory cues directly through the patient's smartphone camera.
- AiCure appoints Ed Ikeguchi, M.D. as its Chief Executive Officer (CEO) to advance AiCure's commitment to improving holistic health through an understanding of the science behind human responses to illness and treatment.
AiCure,
Read More
Airforce to Deploy FDA-Approved Oral Fluid COVID-19 Tests Across US Military
What You Should Know:
COVID-19 testing startup Curative Inc. and Gothams announced it has signed an agreement (phase one is $13m USD) with the U.S. Air Force to deploy its FDA-authorized oral fluid COVID-19 tests and comprehensive testing service to U.S. military personnel around the world.
In this initial agreement, Curative will rapidly
establish a new laboratory facility, fully operational this week, which will
process
Read More
Central, Searchable Repository for all COVID-19 Clinical Trials Launches
What You Need to Know:
- Inato unveils central, searchable repository for all COVID-19 clinical trials designed to support clinical researchers, physicians, and biopharma organizations.
- By centralizing all clinical studies being conducted worldwide and updating trial trends with new information from public registries and aggregators daily, Inato seeks to optimize COVID-19 clinical trial resource allocation and help address any unmet needs as quickly as possible.
Paris-based (and
Read More
IntegriChain Acquires Cumberland’s Life Sciences Division
What You Should Know:
- IntegriChain acquires Cumberland’s Life Sciences division to create life sciences' only comprehensive data and business process platform for market access and commercialization.
- Together, the analytics, applications, managed services and expert advisory services powers 220+ Life Sciences manufacturers' operations and harness the value of their channel, patient and payer data.
IntegriChain, a leading Life Sciences data, and managed services company that
Read More
Medtronic Awarded Emergency Authorization for Compact Ventilator to Support COVID-19 Patients
What You Should Know:
- The company received authorization from the U.S. Food and Drug Administration (FDA) to offer the PB560 ventilator in the U.S. through the agency’s Emergency Use Authorization (EUA) authority.
- Lightweight and compact, the Puritan Bennett™ 560 portable ventilator helps enable patients to live with greater independence while providing caregivers with the peace of mind that comes with a reliable and trusted ventilation system with long battery life.
Medtronic
Read More
Exscientia to Screen 15,000 Drugs in Search for Coronavirus Treatment
What You Should Know:
- Exscientia announced a joint transatlantic initiative with Diamond Light Source, the UK's national synchrotron facility and Calibr, a division of Scripps Research (USA), to screen nearly every known approved and investigational drug against key COVID-19 drug targets to progress compounds that could rapidly become viable drugs for the rapid treatment of the coronavirus.
- Exscientia has gained access to Calibr’s world’s leading collection of 15,000 clinically-ready
Read More
Analysis: Applying AI in the Fight Against The Coronavirus
Drug discovery is a notoriously long, complex and expensive process requiring the concerted efforts of the world’s brightest minds. The complexity in understanding human physiology and molecular mechanisms is increasing with every new research paper published and for every new compound tested. As the world is facing a new challenge in trying to both adapt to and defend itself against the coronavirus, artificial intelligence is offering new hope that a cure might be developed faster than ever
Read More
COVID-19 Treatment and Vaccine Tracker Identifies New Treatments & Vaccines in Development
What You Should Know:
- The Milken Institute launched an effort to track and disseminate accurate information about COVID-19 treatments and vaccines in development.
- Since launch, more than two dozen new candidates have been identified, with some progressing toward clinical trials.
The Milken Institute COVID-19 Treatment and Vaccine Tracker has
identified 16 new treatments in the pipeline along with nine new vaccine candidates
since
Read More
AstraZeneca Selects BrightInsight’s IoT Platform to Focus on Chronic Disease Management
What You Should Know:
- AstraZeneca selects the BrightInsight Platform to build and manage its digital health solutions within a regulatory-compliant environment
- Digital health represents a major opportunity to alleviate some of the biggest concerns in healthcare today—many of which are being amplified due to COVID 19—including the length and cost of clinical trials, better remote testing, and tracking of patients, access to data and delivery of care.
- AstraZeneca and others are
Read More
